FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder

[FDA]

The U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use to treat moderate to severe opioid use disorder (OUD)


Baca selengkapnya di : http://www.fda.gov...